These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34288488)

  • 1. Structure-Activity Relationship Explorations and Discovery of a Potent Antagonist for the Free Fatty Acid Receptor 2.
    Højgaard Hansen A; Christensen HB; Pandey SK; Sergeev E; Valentini A; Dunlop J; Dedeo D; Fratta S; Hudson BD; Milligan G; Ulven T; Rexen Ulven E
    ChemMedChem; 2021 Nov; 16(21):3326-3341. PubMed ID: 34288488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Potent Tetrazole Free Fatty Acid Receptor 2 Antagonists.
    Valentini A; Schultz-Knudsen K; Højgaard Hansen A; Tsakoumagkou A; Jenkins L; Christensen HB; Manandhar A; Milligan G; Ulven T; Rexen Ulven E
    J Med Chem; 2023 May; 66(9):6105-6121. PubMed ID: 37129317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties.
    Hansen AH; Sergeev E; Bolognini D; Sprenger RR; Ekberg JH; Ejsing CS; McKenzie CJ; Rexen Ulven E; Milligan G; Ulven T
    J Med Chem; 2018 Nov; 61(21):9534-9550. PubMed ID: 30247908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: from hit to clinic.
    Pizzonero M; Dupont S; Babel M; Beaumont S; Bienvenu N; Blanqué R; Cherel L; Christophe T; Crescenzi B; De Lemos E; Delerive P; Deprez P; De Vos S; Djata F; Fletcher S; Kopiejewski S; L'Ebraly C; Lefrançois JM; Lavazais S; Manioc M; Nelles L; Oste L; Polancec D; Quénéhen V; Soulas F; Triballeau N; van der Aar EM; Vandeghinste N; Wakselman E; Brys R; Saniere L
    J Med Chem; 2014 Dec; 57(23):10044-57. PubMed ID: 25380412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Thiazolylamide-based free fatty-acid 2 receptor agonists: Discovery, lead optimization and demonstration of off-target effect in a diabetes model.
    Hoveyda HR; Fraser GL; Zoute L; Dutheuil G; Schils D; Brantis C; Lapin A; Parcq J; Guitard S; Lenoir F; Bousmaqui ME; Rorive S; Hospied S; Blanc S; Bernard J; Ooms F; McNelis JC; Olefsky JM
    Bioorg Med Chem; 2018 Oct; 26(18):5169-5180. PubMed ID: 30253886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new homologous series of anticonvulsants: phenyl alcohol amides. Synthesis and pharmacological evaluation.
    Meza-Toledo SE; Zenteno-García MT; Juárez-Carvajal E; Martínez-Muñoz D; Carvajal-Sandoval G
    Arzneimittelforschung; 1990 Dec; 40(12):1289-91. PubMed ID: 2095124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiviral property of allophenylnorstatine-based HIV protease inhibitors incorporating D-cysteine derivatives as P2/P3 moieties.
    Ami E; Nakahara K; Sato A; Nguyen JT; Hidaka K; Hamada Y; Nakatani S; Kimura T; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4213-7. PubMed ID: 17537628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a phenylpyrazole amide ROCK inhibitor as a tool molecule for in vivo studies.
    Hu Z; Wang C; Glunz PW; Li J; Cheadle NL; Chen AY; Chen XQ; Myers JE; Guarino VR; Rose A; Sack JS; Sitkoff D; Taylor DS; Xu S; Yan C; Zhang H; Zhang L; Hennan J; Adam LP; Wexler RR; Quan ML
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127495. PubMed ID: 32798651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and evaluation of a novel monocyclic series of CXCR2 antagonists.
    Austin RP; Bennion C; Bonnert RV; Cheema L; Cook AR; Cox RJ; Ebden MR; Gaw A; Grime K; Meghani P; Nicholls D; Phillips C; Smith N; Steele J; Stonehouse JP
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1616-20. PubMed ID: 25708618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Characterization of a Fluorescent Tracer for the Free Fatty Acid Receptor 2 (FFA2/GPR43).
    Hansen AH; Sergeev E; Pandey SK; Hudson BD; Christiansen E; Milligan G; Ulven T
    J Med Chem; 2017 Jul; 60(13):5638-5645. PubMed ID: 28570808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbazole-containing amides and ureas: Discovery of cryptochrome modulators as antihyperglycemic agents.
    Humphries PS; Bersot R; Kincaid J; Mabery E; McCluskie K; Park T; Renner T; Riegler E; Steinfeld T; Turtle ED; Wei ZL; Willis E
    Bioorg Med Chem Lett; 2018 Feb; 28(3):293-297. PubMed ID: 29292223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of amide-based EP3 receptor antagonists.
    Lee EC; Futatsugi K; Arcari JT; Bahnck K; Coffey SB; Derksen DR; Kalgutkar AS; Loria PM; Sharma R
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2670-5. PubMed ID: 27107947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligands at the Free Fatty Acid Receptors 2/3 (GPR43/GPR41).
    Milligan G; Bolognini D; Sergeev E
    Handb Exp Pharmacol; 2017; 236():17-32. PubMed ID: 27757758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3.
    Schmidt J; Smith NJ; Christiansen E; Tikhonova IG; Grundmann M; Hudson BD; Ward RJ; Drewke C; Milligan G; Kostenis E; Ulven T
    J Biol Chem; 2011 Mar; 286(12):10628-40. PubMed ID: 21220428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 2-(3,5-difluoro-4-methylsulfonaminophenyl)propanamides as potent TRPV1 antagonists.
    Kim C; Ann J; Lee S; Sun W; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2539-2542. PubMed ID: 29884534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.
    Bi Y; Dzierba CD; Fink C; Garcia Y; Green M; Han J; Kwon S; Kumi G; Liang Z; Liu Y; Qiao Y; Zhang Y; Zipp G; Burford N; Ferrante M; Bertekap R; Lewis M; Cacace A; Westphal RS; Kimball D; Bronson JJ; Macor JE
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1443-7. PubMed ID: 25754495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of novel N-phenylbutanamide derivatives as KCNQ openers for the treatment of epilepsy.
    Yang S; Lu D; Ouyang P
    Bioorg Med Chem Lett; 2018 Sep; 28(17):3004-3008. PubMed ID: 30061030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor.
    Hudson BD; Due-Hansen ME; Christiansen E; Hansen AM; Mackenzie AE; Murdoch H; Pandey SK; Ward RJ; Marquez R; Tikhonova IG; Ulven T; Milligan G
    J Biol Chem; 2013 Jun; 288(24):17296-312. PubMed ID: 23589301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor.
    Abdi MH; Beswick PJ; Billinton A; Chambers LJ; Charlton A; Collins SD; Collis KL; Dean DK; Fonfria E; Gleave RJ; Lejeune CL; Livermore DG; Medhurst SJ; Michel AD; Moses AP; Page L; Patel S; Roman SA; Senger S; Slingsby B; Steadman JG; Stevens AJ; Walter DS
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5080-4. PubMed ID: 20673717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of N-substituted-endo-3-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol and -phenyl carboxamide series of μ-opioid receptor antagonists.
    Jiang L; Beattie DT; Jacobsen JR; Kintz S; Obedencio GP; Saito D; Stergiades I; Vickery RG; Long DD
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2926-2930. PubMed ID: 28499731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.